Cibc World Market Inc. Acquires 62,138 Shares of Ventas, Inc. $VTR

Cibc World Market Inc. increased its holdings in shares of Ventas, Inc. (NYSE:VTR) by 23.0% during the fourth quarter, HoldingsChannel.com reports. The fund owned 331,927 shares of the real estate investment trust’s stock after buying an additional 62,138 shares during the quarter. Cibc World Market Inc.’s holdings in Ventas were worth $25,685,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Vanguard Group Inc. grew its stake in Ventas by 3.2% in the 4th quarter. Vanguard Group Inc. now owns 75,948,003 shares of the real estate investment trust’s stock valued at $5,876,856,000 after purchasing an additional 2,349,176 shares during the period. JPMorgan Chase & Co. boosted its holdings in shares of Ventas by 1.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 29,701,300 shares of the real estate investment trust’s stock worth $2,078,794,000 after buying an additional 387,495 shares during the last quarter. State Street Corp boosted its holdings in shares of Ventas by 3.3% in the 3rd quarter. State Street Corp now owns 28,927,015 shares of the real estate investment trust’s stock worth $2,038,176,000 after buying an additional 928,386 shares during the last quarter. Geode Capital Management LLC grew its position in Ventas by 3.8% during the fourth quarter. Geode Capital Management LLC now owns 12,988,943 shares of the real estate investment trust’s stock valued at $1,001,447,000 after buying an additional 475,633 shares during the period. Finally, Dimensional Fund Advisors LP grew its position in Ventas by 2.5% during the third quarter. Dimensional Fund Advisors LP now owns 6,601,143 shares of the real estate investment trust’s stock valued at $462,002,000 after buying an additional 160,998 shares during the period. Hedge funds and other institutional investors own 94.18% of the company’s stock.

Insider Activity

In other news, Director Walter C. Rakowich sold 1,152 shares of the business’s stock in a transaction dated Thursday, May 14th. The stock was sold at an average price of $90.20, for a total transaction of $103,910.40. Following the completion of the transaction, the director owned 28,349 shares of the company’s stock, valued at approximately $2,557,079.80. The trade was a 3.90% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 0.53% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have commented on VTR shares. Wells Fargo & Company lifted their price objective on shares of Ventas from $93.00 to $96.00 and gave the stock an “overweight” rating in a research report on Monday. KeyCorp increased their target price on shares of Ventas from $90.00 to $95.00 and gave the company an “overweight” rating in a research report on Thursday, May 7th. JPMorgan Chase & Co. raised their price target on shares of Ventas from $93.00 to $94.00 and gave the stock an “overweight” rating in a research note on Monday, May 11th. Mizuho set a $98.00 price target on shares of Ventas in a report on Friday, May 22nd. Finally, BMO Capital Markets reiterated an “outperform” rating and issued a $100.00 price objective on shares of Ventas in a research note on Monday, May 4th. Fourteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat, Ventas currently has a consensus rating of “Moderate Buy” and a consensus price target of $95.19.

Ventas Stock Performance

Ventas stock opened at $78.92 on Friday. Ventas, Inc. has a 1-year low of $61.76 and a 1-year high of $91.06. The company has a current ratio of 0.25, a quick ratio of 0.25 and a debt-to-equity ratio of 0.95. The firm has a market capitalization of $38.37 billion, a PE ratio of 143.49, a price-to-earnings-growth ratio of 1.74 and a beta of 0.71. The firm’s 50 day simple moving average is $85.06 and its 200 day simple moving average is $82.36.

Ventas (NYSE:VTR) last released its quarterly earnings results on Monday, April 27th. The real estate investment trust reported $0.11 EPS for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.01). The firm had revenue of $1.65 billion for the quarter, compared to analysts’ expectations of $1.59 billion. Ventas had a net margin of 4.25% and a return on equity of 2.09%. The firm’s revenue for the quarter was up 22.0% on a year-over-year basis. During the same quarter last year, the firm earned $0.84 earnings per share. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. As a group, analysts expect that Ventas, Inc. will post 3.88 earnings per share for the current fiscal year.

Ventas Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, July 16th. Shareholders of record on Tuesday, June 30th will be issued a $0.52 dividend. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $2.08 annualized dividend and a dividend yield of 2.6%. Ventas’s dividend payout ratio (DPR) is presently 378.18%.

Ventas Company Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.